OTSKY News and Press, Otsuka Holdings Co. Ltd. ADR From 05/23/22

Takeda Pharmaceutical will be able to deliver stellar growth during the next decade. China and emerging markets will be a key driver of growth. The current share price is very undervalued considering the long term growth prospects. For further details see: Takeda Pharmac...

Ginkgo Bioworks (DNA) went public last September through an SPAC deal with Soaring Eagle Acquisition Corporation, a blank-check company led by former MGM CEO Harry Sloan. However, the stock has nosedived in price since its market debut. In addition, given an ongoing investigation into the com...

Biotech company Cassava Sciences (SAVA) is known for its Alzheimer’s drug, currently in phase three clinical trials. The stock has gained triple digits so far this year. However, with the SEC investigating claims that the company allegedly manipulated its prior clinical trial results, ...

The sale of COVID-19 vaccines helped Moderna’s (MRNA) revenue soar over the past few quarters. However, its shares plunged nearly 14% in price on December 10 after disappointing results from its experimental seasonal flu shot. So, let’s discuss if it is wise to buy the dip in th...

Aurinia Pharmaceuticals (NASDAQ:AUPH) will report its Q2 2021 earnings after the closing bell today and investors will want to pay attention to sales and any color management provides on its lupus drug Lupkynis (voclosporin). Lupkynis just won FDA approval in January as the first oral th...

The COVID-19 pandemic brought a renewed interest to biotech firms, with many searching for treatments and vaccines. This led to strong returns for many top biotech stocks. But there are smaller, lesser know companies that are also poised for strong returns such as Vanda Pharmaceuticals (VNDA)...

The following slide deck was published by Otsuka Holdings Co., Ltd. in conjunction with this event. For further details see: Otsuka Holdings (OTSKY) Investor Presentation - Slideshow

Quick Take Keros Therapeutics ( KROS ) intends to raise $75 million from the sale of its common stock, per an amended S-1/A regulatory filing . The company is advancing a pipeline of drug treatment candidates for hematological and musculoskeletal diseases. KROS is entering Phase 2 trial...

Otsuka ( OTCPK:OTSKY ) units Astex Pharmaceuticals and Otsuka Pharmaceutical Co. announce positive results from a Phase 3 clinical trial, ASCERTAIN , evaluating the oral fixed-dose combination of cedazuridine and Dacogen (decitabine) (known as ASTX727) in patients with myelodysplastic s...

Alphabet's ( GOOGL , GOOG ) Project Baseline is a data platform from the Verily unit that wants to develop a "well-defined reference" of good health. More news on: Alphabet Inc., Alphabet Inc., Novartis AG, Tech stocks news, Healthcare stocks news, Read more ...